Articles

Elsevier,

Marine Policy, Volume 153, 2023, 105644, ISSN 0308-597X

We are at a critical crossroads for the future governance of the high seas. We used the Nature Futures Framework to explore desirable futures for the high seas. Creative endeavours of co-production encourage imagination to address challenges. Participatory processes are important tools in the science-policy interface. Stories and art can be powerful ways to overcome barriers.
Elsevier,

Sustainable Production and Consumption, Volume 37, May 2023

This study aims to identify the factors that constrain and enable the sustainability of reusable packaging systems, considering environmental, economic, social and technical dimensions. This research is critical to the effective implementation and scale-up of reusable packaging systems.
Elsevier,

Sustainable Production and Consumption, Volume 37, May 2023

This paper explores the potential implementation of the Consumption Footprint rationale to define a footprint indicator for the EU Bioeconomy, henceforth ‘Bioeconomy Footprint’. This indicator can be a powerful tool for a comprehensive and effective monitoring of the bioeconomy sectors: to capture environmental impacts over time, identifying environmental hotspots, highlighting geographic and sectorial trade-offs, and identifying burden shifts among impact categories and along the supply chain.
Elsevier,

The Lancet Planetary Health, Volume 7, May 2023

The 2022 UN Climate Change Implementation Plan acknowledged the necessity of taking action to address climate change and safeguard water and food security within a human-rights-based approach.1 Low-income and middle-income countries are disproportionately affected by climate change and have less capacity to respond to climate-related impacts such as sea-level rise, extreme weather events, drought, population displacement, and disease.
Elsevier,

Cell Chemical Biology, Volume 30, 18 May 2023

Richard et al. provide extensive evidence suggesting that treatment with the HIV-1 attachment inhibitor temsavir can have beneficial effects that extend beyond viral neutralization, notably by preventing elimination of uninfected cells and induction of a cytokine burst caused by its soluble viral glycoprotein.
Elsevier,

The Lancet Global Health, Volume 11, May 2023

This study supports SDG 3 by highlighting that coverage of opioid agonist treatment and syringe exchange programmes (which are associated with reducing HIV transmission) are low in most countries and for the majority of people who inject drugs; although coverage is improving, this is insufficient when compared with the indicator targets set out by WHO, UNAIDS, and the UN Office on Drugs and Crime.
Elsevier,

The Lancet HIV, Volume 10, May 2023

Early treatment of HIV is essential for the health of infants living with HIV; this study looks at ways to improve case-finding.
Elsevier,

The Lancet Healthy Longevity, Volume 4, May 2023

This Article supports SDG 3 by comparing epigenetic ageing during untreated HIV infection and during HIV being treated with antiretroviral therapy. They found that epigenetic ageing was accelarated during the former and decelerated during the latter.
Elsevier,

The Lancet Regional Health - Europe, Volume 28, May 2023

This Article supports SDG 3 by evaluating the effects of a behavioural intersectional stigma coping intervention on stigma and care use. They found that the brief intervention did not change stigma manifestations or drug use behaviours but did reduce the impact of stigma as a barrier to care use.
Elsevier,

The Lancet HIV, Volume 10, May 2023

Dolutegravir is the globally recommended first-line therapy for HIV. In this paper researchers assess the effects of dolutegravir roll-out in the country with the highest HIV burden.

Pages